Cellosaurus LNCaP AR-V7/pLenti (CVCL_A1BL)
Cell line name | LNCaP AR-V7/pLenti |
---|---|
Synonyms | LNCaPAR-V7/pLenti |
Accession | CVCL_A1BL |
Resource Identification Initiative | To cite this cell line use: LNCaP AR-V7/pLenti (RRID:CVCL_A1BL) |
Comments | Population: Caucasian. Characteristics: Inducibly expresses AR variant 7 (ARv7). Developed with the T-REx lentiviral Gateway expression system. Addition of doxycycline (Dox) relieves repression by tetR thus permitting ARv7 induction. Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:644; AR (Note=Isoform ARv7). Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo. Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR. Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056. |
Sequence variations |
|
Disease | Prostate carcinoma (NCIt: C4863) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_1379 (LNCaP clone FGC) |
Sex of cell | Male |
Age at sampling | 50Y |
Category | Cancer cell line |
Publications | PubMed=25008967; DOI=10.1016/j.biocel.2014.06.013; PMCID=PMC4160387 |
Cross-references | |
Cell line databases/resources | cancercelllines; CVCL_A1BL |
Encyclopedic resources | Wikidata; Q102114472 |
Entry history | |
Entry creation | 29-Oct-2020 |
Last entry update | 19-Dec-2024 |
Version number | 9 |